Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1000019, "name": "Alkem Lab", "stock_name": "Alkem Lab", "full_name": "Alkem Laboratories Ltd", "name_url": "stocks-analysis/alkem-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "5,501.60", "chg": 161.6, "chgp": "3.03%", "dir": 1, "prev_price": "5,340.00", "mcapval": "63,856.00 Cr", "mcap": "Mid Cap", "scripcode": 539523, "symbol": "ALKEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE540L01014", "curr_date": "Sep 18, 03:30 PM", "curr_time": "07:27 AM", "last_traded_at": "Sep 18, 03:30 PM IST", "bse_nse_vol": "3.46 lacs", "exc_status": "Active", "traded_date": "Sep 18, 2026", "traded_date_str": "2026 09 18", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Alkem Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-4197202", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_mojoScore_4197202.png", "date": "2026-09-18 10:11:10", "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Alkem Laboratories Declines 1.97%: Bearish Technicals and Flat Earnings Weigh", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-declines-197-bearish-technicals-and-flat-earnings-weigh-4191310", "imagepath": "", "date": "2026-09-12 13:00:49", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>7 Sep:</strong> Downgrade to Sell rating amid technical weakness and flat financials</p>\n <p><strong>7 Sep:</strong> Bearish technical shift confirmed with mixed momentum signals</p>\n <p><strong>11 Sep:</strong> Stock hits 52-week low at Rs.5,052.05 amid market downturn</p>\n <p><strong>11 Sep:</strong> Week closes at Rs.5,089.50, down 1.97%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,192.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..." }, { "title": "Markets Rally, But Alkem Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-stock-hits-52-week-low-amidst-market-downturn-4190145", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_priceRelatedfactors_4190145.png", "date": "2026-09-11 09:51:02", "description": "" }, { "title": "Alkem Laboratories Downgraded to Sell Amid Technical Weakness and Flat Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-technical-weakness-and-flat-financials-4184975", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_mojoScore_4184975.png", "date": "2026-09-07 08:16:51", "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 4 September 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and waning promoter confidence, despite the company’s strong management efficiency and net-debt-free status." }, { "title": "Alkem Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-faces-bearish-technical-shift-amid-mixed-momentum-signals-4184745", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_technicaldot_4184745.png", "date": "2026-09-07 08:03:50", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day gain of 0.14%, the pharmaceutical giant’s technical parameters reveal a complex picture of weakening momentum and cautious investor sentiment as it navigates a challenging market environment." }, { "title": "Alkem Laboratories Ltd Declines 2.96%: 4 Key Technical Shifts Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-declines-296-4-key-technical-shifts-shape-weekly-trend-4183525", "imagepath": "", "date": "2026-09-05 14:01:16", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> Mildly bullish technical momentum shift</p>\n <p><strong>2 Sep:</strong> Technical momentum shifts to sideways trend</p>\n <p><strong>3 Sep:</strong> Death Cross formation signals potential bearish trend</p>\n <p><strong>4 Sep:</strong> Momentum shifts to mildly bearish stance</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,350.15</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.5,192.00</div><div class=\"stat-c..." }, { "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-4181855", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_technicaldot_4181855.png", "date": "2026-09-04 08:05:03", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early September 2026. Despite a modest decline in share price and mixed signals from key technical indicators, the mid-cap pharmaceutical company’s performance relative to the broader market presents a nuanced picture for investors." }, { "title": "Alkem Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-4181507", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_dealthcross_4181507.png", "date": "2026-09-03 18:00:38", "description": "Alkem Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness in the Pharmaceuticals & Biotechnology sector." }, { "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-4178668", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_technicaldot_4178668.png", "date": "2026-09-02 08:07:58", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a recent downgrade from Sell to Hold by MarketsMOJO, the stock’s mixed technical readings suggest cautious optimism amid sector headwinds and broader market volatility." } ], "total": 664, "sid": "1000019", "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "16-Sep-2026", "details": "Alkem Laboratories Limited launches NeuCeno (cenobamate) for the treatment of partial - onset seizures in adult patients.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "15-Sep-2026", "details": "Please find attached herewith intimation for appointment of Dr. Shubhadeep Sinha as Senior Management Personnel of the Company.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "08-Sep-2026", "details": "Alkem Laboratories Limited launches Renocia ExoTM Indias first patented Ginsenoside Exosome - based hair growth serum", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alkem Laboratories Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Aug 26", "dt": "2026-08-07", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

7 Sep: Downgrade to Sell rating amid technical weakness and flat financials

7 Sep: Bearish technical shift confirmed with mixed momentum signals

11 Sep: Stock hits 52-week low at Rs.5,052.05 amid market downturn

11 Sep: Week closes at Rs.5,089.50, down 1.97%

Week Open

Rs.5,192.00

Week Close

Read full news article

Markets Rally, But Alkem Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-09-11 09:51:02

Read full news article

Alkem Laboratories Downgraded to Sell Amid Technical Weakness and Flat Financials

2026-09-07 08:16:51

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 4 September 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and waning promoter confidence, despite the company’s strong management efficiency and net-debt-free status.

Read full news article

Alkem Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals

2026-09-07 08:03:50

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day gain of 0.14%, the pharmaceutical giant’s technical parameters reveal a complex picture of weakening momentum and cautious investor sentiment as it navigates a challenging market environment.

Read full news article

Alkem Laboratories Ltd Declines 2.96%: 4 Key Technical Shifts Shape Weekly Trend

2026-09-05 14:01:16

Key Events This Week

31 Aug: Mildly bullish technical momentum shift

2 Sep: Technical momentum shifts to sideways trend

3 Sep: Death Cross formation signals potential bearish trend

4 Sep: Momentum shifts to mildly bearish stance

Read full news article

Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-04 08:05:03

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early September 2026. Despite a modest decline in share price and mixed signals from key technical indicators, the mid-cap pharmaceutical company’s performance relative to the broader market presents a nuanced picture for investors.

Read full news article

Alkem Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-09-03 18:00:38

Alkem Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness in the Pharmaceuticals & Biotechnology sector.

Read full news article

Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-02 08:07:58

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a recent downgrade from Sell to Hold by MarketsMOJO, the stock’s mixed technical readings suggest cautious optimism amid sector headwinds and broader market volatility.

Read full news article

View All News